|Articles|February 1, 2002

Supplements and Featured Publications

  • New Approaches to the Treatment of Migraine: Clinical and Economic Impact
  • Volume 8
  • Issue 3 Suppl

Migraine: Diagnosis, Management, and New Treatment Options

Download PDF: Migraine: Diagnosis, Management, and New Treatment Options

Articles in this issue

about 24 years ago

Participating Faculty

about 24 years ago

Introduction

about 24 years ago

Almotriptan: A Review of Pharmacology, Clinical Efficacy, and Tolerability

about 24 years ago

Economic Comparison of Oral Triptans for Management of Acute Migraine: Implications for Managed Care

about 24 years ago

Health Outcomes Evaluations: Estimating the Impact of Almotriptan in Managed Care Settings

about 24 years ago

Almotriptan Versus Sumatriptan in Migraine Treatment: Direct Medical Costs of Managing Adverse Chest Symptoms

about 24 years ago

Cost Savings in Migraine Associated with Less Chest Pain on New Triptan Therapy

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text